Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216989 · ClinicalTrials.gov registry record
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
A clinical trial of Insulin Resistance and Fasting, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT07216989 is a study of Insulin Resistance and Fasting that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 15 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07216989, a study of Insulin Resistance and Fasting, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
Conditions Studied
Interventions
- OTHER Fasting
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2026-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07216989
The ClinicalTrials.gov registry entry for NCT07216989 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (94% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Fasting is the first listed.
NCT07216989 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07216989 about?
NCT07216989 is a clinical study titled "Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting". This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
What is the current status of trial NCT07216989?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-08-05. Estimated completion is 2026-10-01.
What conditions does trial NCT07216989 study?
This clinical trial studies the following conditions: Insulin Resistance, Fasting.
What interventions are being tested in trial NCT07216989?
The interventions under investigation include: Fasting (OTHER).
Who is sponsoring clinical trial NCT07216989?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216989 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.